Phase II trial of twice daily oral topotecan in combination with hyperfractionated radiotherapy for limited stage small cell lung carcinoma Conference

Hodge, CW, Legenne, P, Wissel, P et al. (2008). Phase II trial of twice daily oral topotecan in combination with hyperfractionated radiotherapy for limited stage small cell lung carcinoma . JOURNAL OF CLINICAL ONCOLOGY, 26(15), 10.1200/jco.2008.26.15_suppl.7522

Industry Collaboration

keywords

  • Life Sciences & Biomedicine
  • Oncology
  • Science & Technology

Digital Object Identifier (DOI)

publisher

  • AMER SOC CLINICAL ONCOLOGY

volume

  • 26

issue

  • 15